Small-Molecule Injectable Market

Small-molecule injectable sales will rise through 2036, driven by generic small molecule injectables at a 65.0% share of the product segment in 2026. The market is valued at USD 162.4 billion in 2026 and is forecast to reach USD 322.5 billion by 2036 as hospital injectable procurement continues expanding.